Drug Shortage Report for CALMYLIN ACE
Report ID | 195061 |
Drug Identification Number | 02198630 |
Brand name | CALMYLIN ACE |
Common or Proper name | CALMYLIN ACE |
Company Name | TEVA CANADA LIMITED |
Market Status | MARKETED |
Active Ingredient(s) | CODEINE PHOSPHATE PHENIRAMINE MALEATE GUAIFENESIN |
Strength(s) | 10MG 7.5MG 100MG |
Dosage form(s) | SYRUP |
Route of administration | ORAL ORAL |
Packaging size | 500ML |
ATC code | R05FA |
ATC description | COUGH SUPPRESSANTS AND EXPECTORANTS, COMBINATIONS |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | |
Actual start date | 2023-06-16 |
Estimated end date | 2023-10-30 |
Actual end date | 2023-10-30 |
Shortage status | Resolved |
Updated date | 2023-10-31 |
Company comments | OTC not reported on DS |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 30 NOVOPHARM COURT TORONTO, ONTARIO CANADA M1B 2K9 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v1 | 2023-06-16 | English | Compare |
v2 | 2023-06-16 | French | Compare |
v3 | 2023-06-17 | English | Compare |
v4 | 2023-08-17 | English | Compare |
v5 | 2023-08-17 | French | Compare |
v6 | 2023-10-03 | English | Compare |
v7 | 2023-10-03 | French | Compare |
v8 | 2023-10-31 | English | Compare |
Showing 1 to 8 of 8